REG - Dr. Martens PLC - Product and Brand teach-in event

Dr MartensAnnouncement

14/09/2023 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230914:nRSN3469Ma&default-theme=true

RNS Number : 3469M  Dr. Martens PLC  14 September 2023

14 September 2023

Dr. Martens plc

Product and Brand teach-in event

 

Dr. Martens plc is today hosting a teach-in event on product and brand. The
presentation and Q&A session will be webcast live through
www.drmartensplc.com (http://www.drmartensplc.com) from 1.30pm UK time, with a
recording and transcript available afterwards.

 

No material new financial information or targets will be disclosed.

 

Enquiries

 

Investors and analysts

Bethany Barnes, Director of Investor Relations
      +44 7825 187465

 
 
  bethany.barnes@drmartens.com

Beth Callum, Senior Investor Relations
Analyst                    beth.callum@drmartens.com

 

Media
 

Gill Hammond, Director of
Communications                          +44 7384
214248

 

Maitland
            +44 20 7379 5151

Clinton
Manning
+44 7711 972 662

 

 

Financial calendar

The next scheduled event is the first half results on 30 November 2023.

 

About Dr. Martens

Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire.
Produced originally for workers looking for tough, durable boots, the brand
was quickly adopted by diverse youth subcultures and associated musical
movements. Dr. Martens has since transcended its working-class roots while
still celebrating its proud heritage and, six decades later, “Docs” or
“DM’s” are worn by people around the world who use them as a symbol of
empowerment and their own individual attitude. The Company is a constituent of
the FTSE 250 index.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCMZGMLZFKGFZM